Guerrero Ramiro 4
4 · MAIA Biotechnology, Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
MAIA Director Ramiro Guerrero Receives Option Award
What Happened
Ramiro Guerrero, a director of MAIA Biotechnology, was granted a derivative award on 2026-03-31 representing options for 27,258 shares. The Form 4 reports an acquisition with a $0.00 amount, indicating this was a grant (no cash purchase). According to the filing footnote, the options vest 100% on the grant date and are exercisable beginning that date.
Key Details
- Transaction date: 2026-03-31; Form 4 filed 2026-04-02 (appears timely).
- Instrument: Derivative (stock options) for 27,258 shares; filing shows $0.00 as the acquisition amount (reflects a grant).
- Vesting/exercise: Per footnote, options vest 100% on grant date and are immediately exercisable.
- Shares owned after transaction: Not specified in the provided filing details.
- Footnote: Award made under MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan.
Context
This was a compensation-related option grant to a director rather than an open-market purchase or sale. For options, the economic significance depends on the exercise price and future actions (exercise or sale); the filing does not indicate any immediate exercise or sale. Grants are common for executive/director compensation and do not by themselves signal a buy or sell decision.
Insider Transaction Report
- Award
Stock Options
[F1]2026-03-31+27,258→ 27,258 totalExercise: $1.40From: 2026-03-31Exp: 2036-03-31→ Common Stock (27,258 underlying)
Footnotes (1)
- [F1]The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.